February 28 (SeeNews) - Romania will relaunch the sale of its 53.02% stake in drug maker Antibiotice, after announcing its suspension on Wednesday, using a sales procedure in line with European Commission requirements, the government's asset-selling agency, AVAS, said on Thursday.